Resistant Hypertension
71
10
15
27
Key Insights
Highlights
Success Rate
84% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
7.0%
5 terminated out of 71 trials
84.4%
-2.2% vs benchmark
20%
14 trials in Phase 3/4
26%
7 of 27 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 27 completed trials
Clinical Trials (71)
A Study to Investigate the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant Hypertension
Allopurinol Improves Heart Function in African Americans With Resistant Hypertension
Heart Rate Variability and Medication Adherence in Resistant Hypertension
A Study Evaluating Aprocitentan Tablets(SYH9108) for the Treatment of Resistant Hypertension
An Educational Intervention on Medication Adverse Effects in Patients With Resistant Hypertension (HTAR-CSI)
Arterial Stiffness as a Tool to Investigate Adherence in Resistant Hypertension
A Study to Investigate the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant Hypertension
Effect of Nitrate Supplementation on Blood Pressure and Microvascular Function of Resistant Hypertensive Patients
Evaluation of Systemic Microvascular Reactivity in Patients With Resistant Hypertension
The RESPLASH Study
Endothelin-1 Receptor Blockade in Resistant Hypertension
Study of the Prevalence of Endogenous Hypercortisolism in Patients With Resistant Hypertension (MOMENTUM)
A Study to Investigate the Effect of Baxdrostat on Ambulatory Blood Pressure in Participants With Resistant Hypertension
Effect of Electrical Stimulation and Exercise on Blood Flow in Patients With Resistant High Blood Pressure
An Efficacy, Safety, Tolerability and Dose Finding Study of XXB750 in Resistant Hypertension Patients.
A First-in-human Study of HyperQureTM", Laparoscopic Renal Denervation Therapy in Patient With Resistant Hypertension
Early Feasibility Study of "HyperQureTM RDN System", Laparoscopic Renal Denervation Therapy, in Patients With Resistant Hypertension
Perirenal Adipose Tissue Modification Therapy for Resistant Hypertension
Symplicity China Study
Aerobic Exercise and Resistant Hypertension